All In MedTech

Device Trial Radar · NCT06628115

Post Market Study of Cerament V/G in Pedal Osteomyelitis

Post-market Study of Cerament V/G in Foot Osteomyelitis

Last checked: Nov 20, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

25

Actual

Start

Oct 1, 2024

Primary completion

Aug 1, 2026

Study completion Aug 1, 2026

Sponsor

Lead sponsor
Mid and South Essex NHS Foundation TrustAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
BONESUPPORT AB
First posted
Oct 4, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to look at the outcomes of patients who have had bone infection of their feet treated with a licensed antibiotic paste. The main question it aims to answer is: • How does the bone infection heal in response to the antibiotic paste? Participants will: * Undergo standard surgery to remove dead bone and drain any pus. * Antibiotic paste is injected directly into the middle of the bone at surgery. This is instead of receiving antibiotics directly into their bloodstream for 6 weeks. * Recieve one week of tablet antibiotics. * Visit clinic 1 month after surgery for a normal clinical appointment. After, a research team member will ask the participant a few questions. The participant will also have a foot x-ray, wound photograph and fill out a short questionnaire. * Visit clinic 6 months and 12 months following the surgery. A research team member will ask the participant a few questions. The participant will also have a foot x-ray, wound photograph and fill out a short questionnaire.

Conditions

  • Osteomyelitis - Foot

Interventions

  • cerament V or GDevice

    Cerament V or G implantation into forefoot or mid foot bone, and 7-10 days of oral antibiotics.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom from clinical or radiological osteomyelitis in the same or adjacent bone (recorded as yes or no)Time frame: 12 months post-implantion

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mid and South Essex NHS Foundation Trust

    Basildon, Essex, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.